Center for Microbiomics and Human Health
This Center, headed by Dr. Lance B. Price, formerly of the Johns Hopkins School of Medicine, is focusing on using cutting edge molecular technologies to address the complexities of human infections and environmental microbial ecology. The Center is currently developing new metagenomic technologies to explore the human microbiome, particularly the components and dynamics of complex microbial communities associated with infections and chronic disease states. Another focus of the Center is exploring the public health risks associated with non-judicious use of antibiotics.
Current activities include:
- Developing new metagenomic tools capable of accurately identifying the total composition of highly complex microbial communities. These tools require a combination of cutting edge and next generation molecular technologies with high powered computational analysis.
- Exploring the microbiome (total microbial community) of varying wound types, including chronic wounds and severe burns. These explorations require the use of novel metagenomic technologies, as wounds can contain hundreds of different microbial species. The Center will focus on a number of other disease conditions as well.
- Developing research programs to monitor the impact of the non-clinical use of antibiotics (e.g., food animal production) on the spread of antibiotic resistance in local and global communities.
Staff:
Lance Price, Ph.D., Center Director, Associate Investigator
Paul Keim, Ph.D., Division Director & Sr. Investigator
David M. Engelthaler, M.S., Director, Programs & Operations
Barbara Fox-Nellis, Biosafety Director
Tania Contente, M.S., Research Associate III
Andrew Waters, Research Associate II
Jordan Buchhagen, Research Associate I
Lindsey Watson, Research Associate
Kim Pearce, Intern
|
E-MAIL THIS ARTICLE
PRINT THIS PAGE
Podcasts
NewsFeed